The gvhd Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the gvhd Hub cannot guarantee the accuracy of translated content. The gvhd and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The GvHD Hub is an independent medical education platform, sponsored by Medac and supported through grants from Sanofi and Therakos. The funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account and access these new features:
Bookmark content to read later
Select your specific areas of interest
View gvhd content recommended for you
Bipin Savani
Test your knowledge! Take our quick quiz before and after you read this article to find out if you improved your knowledge. Results help us to improve content and continually provide open-access education.
Question 1 of 2
According to a study by Martin et al., what was the leading cause of excess deaths in patients who survived >5 years post-hematopoietic cell transplantation?
A
B
C
D
Video series
On April 14, 2024, the GvHD Hub held a symposium at the 50th European Society for Bone and Marrow Transplantation (EBMT) Annual Meeting on the role of extracorporeal photopheresis (ECP) in the management of chronic graft-versus-host disease (cGvHD).
Here, we share the presentation by Bipin Savani, Vanderbilt University Medical Center, Nashville, US, which explored the long-term burden of cGvHD. Savani discussed organs frequently affected by cGvHD (Figure 1), comorbidities and mortality in patients with cGvHD (Figure 2), and recent progress made in improving the safety of transplantation. He highlighted that mental health disorders, such as anxiety and depression, are prevalent in patients with cGvHD and that the physical burden of symptoms contributes to limitation of daily activities in these patients.
Figure 1. Proportion of patients experiencing mouth, skin, liver, and eye symptoms of cGvHD*
cGvHD, chronic graft-versus-host disease.
*Data from Kurosawa et al.1 and Arora et al.2
Figure 2. Causes of death in long-term survivors of cGvHD*
cGvHD, chronic graft-versus-host disease.
*Adapted from Martin et al.3
Q&A session
This symposium closed with a panel Q&A session with live audience participation, where our panelists shared their perspectives on the value and challenges of ECP in pediatric patients.
Symposium | Q&A | Value and challenges of ECP in pediatric patients
Symposium | The long-term burden of cGvHD
References
Please indicate your level of agreement with the following statements:
The content was clear and easy to understand
The content addressed the learning objectives
The content was relevant to my practice
I will change my clinical practice as a result of this content
More from this series:
